Olokizumab Biosimilar - Research Grade

Human

IL-6

5mg/ml

Human IgG4 S228P Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human IL-6

Blue ice

Interleukin-6 (IL-6) is a pleiotropic cytokine that coordinates inflammation, acute-phase responses, and immune cell behaviour, and is among the most studied targets in inflammatory disease research. Our anti-human IL-6 recombinant monoclonal is an unconjugated, non-therapeutic analog of olokizumab, supplied strictly for research use only (RUO). Produced to in vivo standards, the low-endotoxin formulation is delivered in scalable milligram (mg) to gram (g) batches for heavy-usage and high-throughput facilities. It acts as a neutralising and control reagent across in vitro cytokine assays, ex vivo signalling studies, and in vivo inflammatory models, offering reliable consistency across large experimental campaigns.

P05231

ICH3002

https://www.imgt.org/mAb-DB/